Wolfgang E. Berdel
Impact in
- Hematology top 0.05%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Multiple Myeloma Research and Treatments
- Cancer Research top 0.2%
- Cancer-related molecular mechanisms research
Papers in
- Hematology 231
- Acute Myeloid Leukemia Research 159
- Multiple Myeloma Research and Treatments 52
- Chronic Myeloid Leukemia Treatments 42
- Hematopoietic Stem Cell Transplantation 39
- Genetics 80
- Myeloproliferative Neoplasms: Diagnosis and Treatment 42
- Co-authors
- Carsten Müller‐TidowHubert ServeRolf M. MestersJoachim KienastSven DiederichsEtmar BulkMichael ThomasThomas Büchner
- Journals
- Blood (95 papers)Journal of Clinical Oncology (22 papers)PLoS ONE (22 papers)Annals of Hematology (18 papers)Leukemia (11 papers)
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
Wolfgang E. Berdel
487 papers receiving 20.9k citations
Hit Papers
Peers
Comparison fields: 5 of 167
- Hematology 7.3k
- Cancer Research 4.3k
- Genetics 2.5k
- Oncology 5.1k
- Molecular Biology 11.3k
Countries citing papers authored by Wolfgang E. Berdel
This map shows the geographic impact of Wolfgang E. Berdel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wolfgang E. Berdel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wolfgang E. Berdel more than expected).
Fields of papers citing papers by Wolfgang E. Berdel
This network shows the impact of papers produced by Wolfgang E. Berdel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wolfgang E. Berdel. The network helps show where Wolfgang E. Berdel may publish in the future.
Co-authors
The 25 scholars most cited alongside Wolfgang E. Berdel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 0 | |
| 2 | 2022 | 1 | |
| 3 | 2021 | 5 | |
| 4 | 2018 | 4 | |
| 5 | 2018 | 46 | |
| 6 | 2015 | 92 | |
| 7 | 2013 | 41 | |
| 8 | 2012 | 61 | |
| 9 | 2011 | 19 | |
| 10 | 2009 | 189 | |
| 11 | 2009 | 48 | |
| 12 | 2009 | 12 | |
| 13 | 2008 | 232 | |
| 14 | 2007 | 81 | |
| 15 | 2004 | 168 | |
| 16 | 2003 | 238 | |
| 17 | Overexpression of basic fibroblast growth factor and autocrine stimulation in acute myeloid leukemia. | 2003 | 56 |
| 18 | 1995 | 17 | |
| 19 | 1993 | 11 | |
| 20 | The Cell Membrane and Cell Signals as Targets in Cancer Chemotherapy AACR, EORTC, and BACR Special Conference in Cancer Research | 1990 | 7 |
About Wolfgang E. Berdel
Wolfgang E. Berdel is a scholar working on Hematology, Genetics, Oncology, Molecular Biology and Cancer Research, having authored 502 papers that have together received 21.3k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (159 papers), Multiple Myeloma Research and Treatments (52 papers), Acute Lymphoblastic Leukemia research (43 papers), Chronic Myeloid Leukemia Treatments (42 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (42 papers), Hematopoietic Stem Cell Transplantation (39 papers), Peptidase Inhibition and Analysis (35 papers) and Lymphoma Diagnosis and Treatment (32 papers). The work is most often cited by research in Hematology (7.3k citations), Cancer Research (4.3k citations), Genetics (2.5k citations), Oncology (5.1k citations) and Molecular Biology (11.3k citations). Wolfgang E. Berdel has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Carsten Müller‐Tidow, Hubert Serve, Rolf M. Mesters, Joachim Kienast, Sven Diederichs, Etmar Bulk, Michael Thomas, Thomas Büchner, Ping Ji and Teresa Padró. Their work appears in journals such as Blood, Journal of Clinical Oncology, PLoS ONE, Annals of Hematology and Leukemia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.